Breaking News on Contract Research, Manufacturing & Clinical Trials

Library > On-Demand Supplier Webinar

Biomarkers of Metabolic Syndrome in Clinical Trials

Published: 14-Feb-2011 | Format: Webinar | Document type: Supplier Webinar
Related applications: Phase I-II , Phase III-IV , Preclinical
Pacific Biomarkers, Inc.

PBI scientists will discuss latest developments in biomarkers for metabolic syndrome. Topics: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) Dysfunctional HDL biomarkers in metabolic syndrome, and 3) Kidney Injury Markers and their usefulness in diabetic nephropathy. Attendees would include scientists and physicians involved in drug-development with focus on biomarker selections for clinical trials.

Speakers:

  • Amar A. Sethi

    Amar A Sethi

    Vice President Research and Development

    Pacific Biomarkers, Inc.

  • Dorota Schranz

    Dorota Schranz

    Director Biomarker Development & Validations

    Pacific Biomarkers, Inc.

  • Timothy Carlson

    Timothy Carlson

    Laboratory Director/Senior Director of Biomarker Innovation

    Pacific Biomarkers, Inc.

Supplier's Info Centre

Logo

Fill Form to Watch Now!

*
*
*
*
*
*
*
*
*

YesNo

Please note that any information that you supply is protected by our Privacy and Cookie Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.